About the Authors

  • The Authors and Contributors of "Patent Docs" are patent attorneys and agents, many of whom hold doctorates in a diverse array of disciplines.
2018 Juristant Badge - MBHB_165
Juristat #4 Overall Rank

E-mail Newsletter

  • Enter your e-mail address below to receive the "Patent Docs" e-mail newsletter.
Subscribe to this blog's feed

Contact the Docs

Recent Posts

Disclaimer

  • "Patent Docs" does not contain any legal advice whatsoever. This weblog is for informational purposes only, and its publication does not create an attorney-client relationship. In addition, nothing on "Patent Docs" constitutes a solicitation for business. This weblog is intended primarily for other attorneys. Moreover, "Patent Docs" is the personal weblog of the Authors; it is not edited by the Authors' employers or clients and, as such, no part of this weblog may be so attributed. All posts on "Patent Docs" should be double-checked for their accuracy and current applicability.
Juristat_165
Juristat #8 Overall Rank

Pharma-50-transparent_216px_red

« Hassle-Free Filing of Sequence Listings on EFS-Web Version 1.1 | Main | BIO-Asia Partnering Conference »

November 17, 2006

NeuroMedix Inc.

    By Jason Derry --Logo_5

NeuroMedix Inc., a biotechnology company seeking therapeutic approaches for treating neuronal diseases, has announced the intent to pursue partners or acquisition possibilities.  The company currently has a potential product, Minozac, in pre-clinical studies, and is preparing to submit the Phase I safety application for continuing clinical trial progression.  Minozac is NeuroMedix’s lead product for the treatment of Alzheimer’s disease and other diseases of the central nervous system.  NeuroMedix has indicated that the intent to explore merger and acquisition possibilities does not guarantee that such a relationship will be formed.  A Fact Sheet discussing company goals and providing additional information about Minozac in particular can be found here.

Jason Derry, Ph.D., who graduated with honors from DePaul University College of Law, is a molecular biologist and founding author of Patent Docs.

Posted at 11:19 AM in Biotech/Pharma Business |

Comments

The comments to this entry are closed.

September 2024

Sun Mon Tue Wed Thu Fri Sat
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30          

Categories

Archives

More...